The role of nitric oxide in the formation of keloid and hypertrophic lesions - PubMed (original) (raw)
. 2001 Oct;57(4):497-502.
doi: 10.1054/mehy.2001.1373.
Affiliations
- PMID: 11601878
- DOI: 10.1054/mehy.2001.1373
The role of nitric oxide in the formation of keloid and hypertrophic lesions
C A Cobbold. Med Hypotheses. 2001 Oct.
Abstract
Keloid and hypertrophic scars are a type of scarring pathology which is characterised by excess collagen deposition produced during the wound healing process. The mechanism by which this occurs is not understood and although hypertrophic scars can regress spontaneously, keloids do not, and currently no effective treatment exists. In this paper we hypothesise that nitric oxide, a free radical molecule synthesised by numerous mammalian cells, is involved in the formation of these scars. We suggest that the excess collagen production in keloid lesions can be attributed to higher than normal levels of nitric oxide, as the free radical is a known stimulus for fibroblast collagen synthesis. Furthermore, we propose that the basal epidermis is a source of this additional nitric oxide and we discuss this in relation to known histological characteristics of keloid and hypertrophic lesions.
Copyright 2001 Harcourt Publishers Ltd.
Similar articles
- Mathematical modelling of nitric oxide activity in wound healing can explain keloid and hypertrophic scarring.
Cobbold CA, Sherratt JA. Cobbold CA, et al. J Theor Biol. 2000 May 21;204(2):257-88. doi: 10.1006/jtbi.2000.2012. J Theor Biol. 2000. PMID: 10887905 - Keloids and hypertrophic scars: are they two different sides of the same coin?
Köse O, Waseem A. Köse O, et al. Dermatol Surg. 2008 Mar;34(3):336-46. doi: 10.1111/j.1524-4725.2007.34067.x. Epub 2007 Dec 19. Dermatol Surg. 2008. PMID: 18177398 Review. - Hypertrophic scars and keloids.
Haverstock BD. Haverstock BD. Clin Podiatr Med Surg. 2001 Jan;18(1):147-59. Clin Podiatr Med Surg. 2001. PMID: 11344975 Review. - Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.
Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H. Wolfram D, et al. Dermatol Surg. 2009 Feb;35(2):171-81. doi: 10.1111/j.1524-4725.2008.34406.x. Dermatol Surg. 2009. PMID: 19215252 Review. - The molecular basis of keloid and hypertrophic scar formation.
Tuan TL, Nichter LS. Tuan TL, et al. Mol Med Today. 1998 Jan;4(1):19-24. doi: 10.1016/S1357-4310(97)80541-2. Mol Med Today. 1998. PMID: 9494966 Review.
Cited by
- Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarification.
Zheng Y, Huang Q, Zhang Y, Geng L, Wang W, Zhang H, He X, Li Q. Zheng Y, et al. Front Immunol. 2023 Aug 29;14:1237992. doi: 10.3389/fimmu.2023.1237992. eCollection 2023. Front Immunol. 2023. PMID: 37705977 Free PMC article. Review. - Keloid progression: a stiffness gap hypothesis.
Huang C, Liu L, You Z, Wang B, Du Y, Ogawa R. Huang C, et al. Int Wound J. 2017 Oct;14(5):764-771. doi: 10.1111/iwj.12693. Epub 2016 Dec 19. Int Wound J. 2017. PMID: 27995750 Free PMC article. - Synthetic, Natural, and Semisynthetic Polymer Carriers for Controlled Nitric Oxide Release in Dermal Applications: A Review.
Gutierrez Cisneros C, Bloemen V, Mignon A. Gutierrez Cisneros C, et al. Polymers (Basel). 2021 Feb 28;13(5):760. doi: 10.3390/polym13050760. Polymers (Basel). 2021. PMID: 33671032 Free PMC article. Review. - Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells.
Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, Whitaker-Menezes D, Daumer KM, Lin Z, Witkiewicz AK, Flomenberg N, Howell A, Pestell RG, Knudsen ES, Sotgia F, Lisanti MP. Martinez-Outschoorn UE, et al. Cell Cycle. 2010 Aug 15;9(16):3256-76. doi: 10.4161/cc.9.16.12553. Epub 2010 Aug 28. Cell Cycle. 2010. PMID: 20814239 Free PMC article.